Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Tolvaptan Extension Study in Participants With ADPKD

ClinicalTrials.gov ID: NCT01214421

Public ClinicalTrials.gov record NCT01214421. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 2:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To demonstrate whether tolvaptan modifies ADPKD progression as measured by changes from Baseline (from Study 156-04-251) in total kidney volume (TKV) and renal function.

Study identification

NCT ID
NCT01214421
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
1,083 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 25, 2010
Primary completion
Feb 28, 2016
Completion
Feb 28, 2016
Last update posted
Oct 24, 2021

2010 – 2016

United States locations

U.S. sites
38
U.S. states
24
U.S. cities
36
Facility City State ZIP Site status
Otsuka Investigational Site Mobile Alabama 36617
Otsuka Investigational Site Peoria Arizona 85381
Otsuka Investigational Site Tempe Arizona 85284
Otsuka Investigational Site Los Angeles California 90025
Otsuka Investigational Site Palo Alto California 94304
Otsuka Investigational Site San Diego California 92108
Otsuka Investigational Site Aurora Colorado 80045
Otsuka Investigational Site New Haven Connecticut 06510
Otsuka Investigational Site Jacksonville Florida 32216
Otsuka Investigational Site Port Charlotte Florida 33952
Otsuka Investigational Site Atlanta Georgia 30322
Otsuka Investigational Site Augusta Georgia 30909
Otsuka Investigational Site Chicago Illinois 60611
Otsuka Investigational Site Kansas City Kansas 66160
Otsuka Investigational Site Baton Rouge Louisiana 70808
Otsuka Investigational Site Baltimore Maryland 21205
Otsuka Investigational Site Rockville Maryland 20850
Otsuka Investigational Site Boston Massachusetts 02111
Otsuka Investigational Site Detroit Michigan 48236
Otsuka Investigational Site Minneapolis Minnesota 55404
Otsuka Investigational Site Rochester Minnesota 55905
Otsuka Investigational Site Voorhees Township New Jersey 08043
Otsuka Investigational Site Buffalo New York 14215
Otsuka Investigational Site Hawthorne New York 10532
Otsuka Investigational Site New York New York 10021
Otsuka Investigational Site New York New York 10032
Otsuka Investigational Site Chapel Hill North Carolina 27599
Otsuka Investigational Site Cincinnati Ohio 45246
Otsuka Investigational Site Cleveland Ohio 44106
Otsuka Investigational Site Portland Oregon 97210
Otsuka Investigational Site Bethlehem Pennsylvania 18017
Otsuka Investigational Site Philadelphia Pennsylvania 19104
Otsuka Investigational Site Anderson South Carolina 29621
Otsuka Investigational Site Nashville Tennessee 37205
Otsuka Investigational Site Nashville Tennessee 37232
Otsuka Investigational Site Arlington Texas 76015
Otsuka Investigational Site McAllen Texas 78503
Otsuka Investigational Site Charlottesville Virginia 22908

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 59 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01214421, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 24, 2021 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01214421 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →